ConvaTec Group PLC
LSE:CTEC

Watchlist Manager
ConvaTec Group PLC Logo
ConvaTec Group PLC
LSE:CTEC
Watchlist
Price: 222 GBX 0.45% Market Closed
Market Cap: 4.6B GBX
Have any thoughts about
ConvaTec Group PLC?
Write Note

Net Margin
ConvaTec Group PLC

7%
Current
5%
Average
2.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
7%
=
Net Income
153.2m
/
Revenue
2.2B

Net Margin Across Competitors

Country UK
Market Cap 4.6B GBP
Net Margin
7%
Country JP
Market Cap 7T JPY
Net Margin
24%
Country CH
Market Cap 38.2B CHF
Net Margin
12%
Country DK
Market Cap 177.1B DKK
Net Margin
19%
Country US
Market Cap 16.3B USD
Net Margin
11%
Country KR
Market Cap 10.3T KRW
Net Margin
-358%
Country CN
Market Cap 51B CNY
Net Margin
42%
Country US
Market Cap 6.7B USD
Net Margin
29%
Country CA
Market Cap 6.3B USD
Net Margin
-8%
Country US
Market Cap 5.6B USD
Net Margin
9%
Country CH
Market Cap 4.7B CHF
Net Margin
12%
No Stocks Found

ConvaTec Group PLC
Glance View

Market Cap
4.6B GBX
Industry
Health Care

ConvaTec Group PLC is a notable player in the realm of medical products and technologies, deftly weaving its narrative within the healthcare industry. Founded in 1978, the company has steadily established itself through strategic expansion and innovation, focusing on improving the lives of patients and enhancing healthcare delivery. The company's core business revolves around four main product categories: Advanced Wound Care, Ostomy Care, Continence and Critical Care, and Infusion Care. Each of these sectors is backed by a robust commitment to research and development, allowing ConvaTec to deliver specialized products that cater to both specific patient needs and broader healthcare system demands. ConvaTec's financial model centers around providing essential, high-quality medical solutions that ultimately support improved patient outcomes. The company garners revenue by partnering with hospitals, healthcare providers, and direct consumer channels, ensuring its products reach where they are most needed. With a global footprint spanning multiple continents, ConvaTec not only distributes its products widely but also adapts its strategy to meet the nuanced requirements of diverse markets. By aligning itself closely with caregivers and leveraging cutting-edge technology, the company maintains a sustainable economic engine through both recurring sales from consumables and long-term relationships with its institutional clients.

CTEC Intrinsic Value
286.3 GBX
Undervaluation 22%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
7%
=
Net Income
153.2m
/
Revenue
2.2B
What is the Net Margin of ConvaTec Group PLC?

Based on ConvaTec Group PLC's most recent financial statements, the company has Net Margin of 7%.